CSPAX
Price
$72.82
Change
-$0.70 (-0.95%)
Updated
Aug 14 closing price
Net Assets
81.12B
RSLFX
Price
$77.96
Change
-$0.75 (-0.95%)
Updated
Aug 14 closing price
Net Assets
81.12B
Interact to see
Advertisement

CSPAX vs RSLFX

Header iconCSPAX vs RSLFX Comparison
Open Charts CSPAX vs RSLFXBanner chart's image
American Funds SMALLCAP World 529A
Price$72.82
Change-$0.70 (-0.95%)
VolumeN/A
Net Assets81.12B
American Funds SMALLCAP World R5
Price$77.96
Change-$0.75 (-0.95%)
VolumeN/A
Net Assets81.12B
CSPAX vs RSLFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSPAX vs. RSLFX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPAX is a Buy and RSLFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSPAX (81.1B) and RSLFX (81.1B) have equal amount of cash in the bank . RSLFX pays higher dividends than CSPAX: RSLFX (0.86) vs CSPAX (0.58). CSPAX was incepted earlier than RSLFX: CSPAX (24 years) vs RSLFX (23 years). CSPAX (1.06) is less costly to investors than RSLFX (0.70). CSPAX (32.00) and RSLFX (32.00) have comparable annual turnover. CSPAX (250) and RSLFX (250) have matching initial minimum investment requirements. RSLFX (12.85) and CSPAX (12.45) have marching annual gain over last year. RSLFX return over 5 years is better than : 17.72 vs. CSPAX (15.23).
CSPAXRSLFXCSPAX / RSLFX
Total Expense Ratio1.060.70151%
Annual Report Gross Expense Ratio1.060.70151%
Fund Existence24 years23 years-
Gain YTD9.92210.16598%
Front Load4%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets81.1B81.1B100%
Annual Yield % from dividends0.580.8667%
Returns for 1 year12.4512.8597%
Returns for 3 years21.7022.7196%
Returns for 5 years15.2317.7286%
Returns for 10 years50.5157.1588%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INUV3.930.15
+3.97%
Inuvo
BAYAU11.35N/A
N/A
Bayview Acquisition Corp
WTFC127.88-0.57
-0.44%
Wintrust Financial Corp
TXG13.24-0.33
-2.43%
10x Genomics
FULC6.60-0.25
-3.65%
Fulcrum Therapeutics